CA9 and neoplasm: The decrease in blood flow was consistent with CD31immunohistochemical analysis, where a significant reduction in tumor vascularizationwas observed (Figure 4).The decreases in tumor vascularization and blood flow observed here were accompaniedby an increase in CA-9 labeling compared to the untreated control (Figure 6).